NorthWest Biotherapeutics Inc (NWBO)

[Tadasana]

cdrd, shouldn't there be two medians? one for control (110 patients median at 55th patient death then if there are alive patients in control group they will be censored at time trial is unblinded) for vaccine (220 patients median at 110 patient death with rest alive patients censored) median should be 165 patient for blended in a trial of 331, and only patients that die to the left of the median will move the median left other wise if to the right of median will have no effect? That is why they wait for the long tail to appear for the 25-30% of patients that don't die and are alive at the long tail. This is when the curves separate for the vaccinated versus control arms, but ours will be confounded slightly due to crossover affect but still the PFS numbers will not be confounded and it will clearly show the long tail of survivors in the vaccinated arm the are alive and PFS. imho